title: Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Corso
authors.forename: Angela
authors.initials: A
authors.lastname: Lorenzi
authors.forename: Patrizia
authors.initials: P
authors.lastname: Zappasodi
authors.forename: Rosangela
authors.initials: R
authors.lastname: Invernizzi
authors.forename: Laura
authors.initials: L
authors.lastname: Vanelli
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D004334:Drug Administration Schedule; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology*; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide